Skip to main content
Top

Drugs

Issue 11/2012

Content (10 Articles)

Orphan Drugs for Rare Diseases

  • Current Opinion

Steven Simoens, David Cassiman, Marc Dooms, Eline Picavet

Therapeutic Potential of Mipomersen in the Management of Familial Hypercholesterolaemia

  • Leading Article

Carmen Gelsinger, Elisabeth Steinhagen-Thiessen, Ursula Kassner

Delirium in Critically Ill Patients

  • Therapy In Practice

Irene J. Zaal, Arjen J. C. Slooter

Ten Years of Experience with Biphasic Insulin Aspart 30

  • Open Access
  • Review Article

Andreas Liebl, Vinay Prusty, Paul Valensi, Ryuzo Kawamori, Jens Sandahl Christiansen, Andrew J. Palmer, Per Balschmidt, Robert Ligthelm, Viswanathan Mohan

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis

  • Systematic Review

Lin-lin Liu, Yi Jiang, Li-ning Wang, Li Yao, Zi-long Li

Vismodegib

  • Adis Drug Profile

Gillian M. Keating

Docetaxel

  • Adis Drug Evaluation

Kate McKeage

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images